Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


DTC Advertising Is Back With A Bang

Executive Summary

The pharmaceutical industry spent roughly $6bn in 2015 on direct-to-consumer advertising, and the upswing is expected to continue due to favorable economics. Most of the dollars go to TV ads, with more emphasis on targeted patient groups.

You may also be interested in...

Diabetes DTC Ads Stand Out For Off-Label Promotion, Study Finds

Drugs like Victoza, Farxiga, Jardiance, Trulicity, and Invokana were called out for promoting weight loss and blood pressure reduction by Yale University researchers in a new study published in the Journal of General Internal Medicine.

The Return Of The US Pharma Sales Force

The number of pharmaceutical sales reps in the US grew to the highest levels in 2016 since 2011. The trend has continued in 2017, fueled by growth in oncology, where there have been new launches.

Bridging The Drug Price Divide: Ideas And Approaches Debated At PSA

Leaders from across the industry met at Informa's Pharmaceutical Strategy conference and addressed some of the most critical issues facing the industry: pharma's tarnished reputation and drug pricing.

Related Content


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts